To Be Discontinued Tablet Gastroenterology
Obeticholic Acid Tablet · 357 days since initial FDA posting
FDA lists Obeticholic Acid Tablet as To Be Discontinued (Intercept Pharmaceuticals).
No availability text on this FDA row.
Obeticholic Acid Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Obeticholic Acid Tablet
- Manufacturer
- Intercept Pharmaceuticals
- Dosage Form
- Tablet
- Presentation
- Ocaliva, Tablet, 10 mg (NDC 69516-010-30)
- Package NDC
- 69516-010-30
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Sep 19, 2025
- Last Updated
- Sep 19, 2025
- Therapeutic Category
- Gastroenterology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Business decision. Products will not be available after November 14, 2025.
Nearby, Other Obeticholic Shortage Records
FDA reason on file: Business decision. General shortage guidance lives on the tracker hub.